June 1, 2023

Six Early-Career UAMS Researchers Receive KL2 Scholar Awards

David Robinson

The 2023-2024 KL2 Scholars are (l-r, clockwise from top): Mary “Katy” Allison, Michail Mavros, Brian D. Piccolo, Megha Sharma, Ankita Shukla and Alicja Urbaniak.

Six early-career researchers have been selected to receive two years of funded translational research training and support in the UAMS Translational Research Institute (TRI) KL2 Mentored Research Career Development Scholar Awards Program. The promising junior faculty researchers were selected for the 2023-2024 program through a competitive application process. KL2 scholars receive two years of mentored…


May 24, 2023

UAMS-TRI Training Program Helps Postdocs Develop Entrepreneurial Spirit, Form Competition-Winning Pharmaceutical Startup

David Robinson

Megan Reed, Ph.D. (left), and Julia Tobacyk, Ph.D., formed the company Pediatrica Therapeutics.

Only two years ago, the idea of commercializing their future research discoveries was a novel concept for Julia Tobacyk, Ph.D., and Megan Reed, Ph.D. Today they can say they created a startup company as postdoctoral fellows in the Health Sciences Innovation and Entrepreneurship (HSIE) training program, which is the National Institutes of Health’s (NIH) National…


May 23, 2023

UAMS Surgeons Implant Innovative Device Developed by I3R Researchers to Restore Sense of Touch after Amputation

David Robinson

Erika Petersen, M.D., seated, pauses to look at a monitor as the surgery begins with (l-r) John Bracey, M.D., Brooke Elberson, M.D., Ph.D., Bridgette Vinyard-Hartwick, and Mark Tait, M.D. (photo by Evan Lewis)

LITTLE ROCK — The first Arkansan and only second person in the world has received an innovative prosthetic hand, developed by researchers at the Institute for Integrative and Innovative Research (I³R), that restores a meaningful sense of touch and grip force following surgery at the University of Arkansas for Medical Sciences (UAMS). The lengthy and…


May 16, 2023

BioVentures Introduces New Leadership, Expanded Resources at Commercialization Retreat

David Robinson

UAMS Chancellor Cam Patterson, M.D., MBA, said having a great team is the key to success as an entrepreneur.

The first BioVentures Commercialization Retreat drew 65 attendees to a full-day of  presentations packed with helpful information and inspirational stories. The presenters included keynote speaker Kevin Sexton, M.D., president of BioVentures LLC, and UAMS Chancellor Cam Patterson, M.D., MBA, whose 2016 book, “Research to Revenue: A Practical Guide to University Start-Ups,” was available for free…


May 15, 2023

American Cancer Society Funds UAMS Study of ACA’s Impact on Breast Cancer Treatment

David Robinson

Chenghui Li, Ph.D., said findings from her study should provide important insights into how the Affordable Care Act has impacted racial disparities in breast cancer treatment.

LITTLE ROCK — An American Cancer Society grant will support a University of Arkansas for Medical Sciences (UAMS) study of the Affordable Care Act’s (ACA) influence on racial disparities in the use of a common, life-saving treatment for Arkansas breast cancer patients. The two-year, $222,000 grant is led by Chenghui Li, Ph.D., an associate professor…


May 2, 2023

Christi Madden, MPA, Named Executive Director of UAMS Translational Research Institute

David Robinson

Christi Madden, MPA, has joined the Translational Research Institute as executive director.

LITTLE ROCK — Christi Madden, MPA, has joined the UAMS Translational Research Institute as its executive director. Madden, a leader with more than two decades of research programmatic management experience, spent most of her career in her home state of Oklahoma at the University of Oklahoma Health Sciences Center (OUHSC), where she worked in the…


May 1, 2023

UAMS, NIH Study Finds Consoling, Other Techniques Better Than Drug Therapies for Newborns with Opioid Withdrawal

David Robinson

UAMS’ Jessica Snowden, M.D., said the study’s findings provide the first strong evidence needed to help end hospitals’ widely varying treatments of Neonatal Opioid Withdrawal Syndrome.

LITTLE ROCK — A groundbreaking nationwide clinical trial in which the University of Arkansas for Medical Sciences (UAMS) played a key role has confirmed an effective way to wean newborns from opioid withdrawal symptoms that substantially reduces hospital stays and the traditional use of drug therapies. Using an “Eat, Sleep, Console” (ESC) care approach resulted…


April 17, 2023

UAMS’ Laura James, M.D., Re-Elected to National Science Board

David Robinson

Laura James, M.D.

LITTLE ROCK — Laura James, M.D., director of the UAMS Translational Research Institute, has been elected to a second term on the national Association for Clinical and Translational Science (ACTS) Board of Directors. She joins 13 other directors at large from National Institutes of Health (NIH)-funded Clinical and Translational Science Awards (CTSA) Program institutions across…


April 6, 2023

UAMS Invites Public to Attend Community Scientist Academy May 5, 26

David Robinson

LITTLE ROCK — The public is invited to attend a free, two-day Community Scientist Academy workshop at UAMS on Friday, May 5, and Friday, May 26. The academy will be held from 10 a.m. to 3 p.m. each day. The workshop is for anyone in the community interested in learning more about health research and…


March 27, 2023

NIH, NSF Fund UAMS Study of Rapid Genomic Testing to Aid Treatment of Dangerous Antibiotic-Resistant Infections

David Robinson

Se-Ran Jun, Ph.D., hopes her research will lead to rapid, life-saving genomic information for doctors treating the most dangerous antibiotic-resistant infections.

LITTLE ROCK — Two national grants are helping researchers at the University of Arkansas for Medical Sciences (UAMS) toward their goal of providing rapid, life-saving genomic information to doctors treating the most dangerous antibiotic-resistant infections. The study began with a $50,000 pilot award from the UAMS Translational Research Institute, which was used to gather data…



Previous page Next page